Table 2.
Subject blood, comorbidity, and medication data
| Healthy Control Subjects | Patients With Peripheral Artery Disease | |
|---|---|---|
| Glucose, mg/dl | 88 ± 6 | 110 ± 9 |
| Cholesterol, mg/dl | 199 ± 33 | 165 ± 14 |
| Triglycerides, mg/dl | 101 ± 15 | 147 ± 28 |
| High-density lipoprotein, mg/dl | 58 ± 6 | 42 ± 2* |
| Low-density lipoprotein, mg/dl | 130 ± 6 | 95 ± 14* |
| White blood cells, k/μl | 6.3 ± 0.7 | 7.9 ± 0.6 |
| Red blood cells, k/μl | 4.9 ± 0.1 | 4.5 ± 0.1* |
| Hemoglobin, g/dl | 14.2 ± 1.0 | 14.5 ± 0.5 |
| Hematocrit, % | 45.5 ± 0.8 | 43.2 ± 1.2 |
| O2 saturation, % | 95.2 ± 1.3 | 94.3 ± 1.7 |
| Coronary artery disease, n | 0 | 40 |
| Myocardial infraction, n | 0 | 20 |
| Hypertension, n | 0 | 30 |
| Diabetes mellitus, n | 0 | 10 |
| Renal insufficiency, n | 0 | 10 |
| Medications, % | ||
| Statins medication | 0 | 40 |
| Aspirin/clopidogrel | 20 | 100 |
Values are expressed as means ± SE; n, number of patients/group.
*
Significant difference between groups (P < 0.05).